PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a nationwide study of pregnant or recently pregnant women who are either under investigation for Coronavirus infection (COVID-19) or have been confirmed to have COVID-19. Yalda Afshar, MD, PhD, a UCLA OBGYN maternal fetal medicine specialist, is a CO-PI on this study that is overseen by a team from UCSF and which is being done to help patients and doctors better understand how COVID-19 impacts pregnant women and their newborns.
For more information > | Study flyer >
The UCLA OBGYN physicians are nationally and internationally recognized not only for their clinical expertise but also for their pioneering research. Our goal is to increase basic research and translate the findings into clinical trials.
What is a clinical trial? A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help our patients.
Cancer - Ovarian, Fallopian Tube and Peritoneal Cancer
Primary Ovarian Cancer: A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O)
Cancer - Uterine and Endometrial
Cancer - Cervical
Benign / Non-Cancer
For more information about clinical trials at UCLA Obstetrics and Gynecology, please call Sonali S. Namiranian, BS, MBA-BT, CCRP at (310) 794-9095 or e-mail her at email@example.com.
Clinical Trial Resources: